ClinicalTrials.Veeva

Menu

Comparison of Congenital Pneumonia and Transient Tachypnea of the Newborn

D

Dr. Behcet Uz Children's Hospital

Status

Enrolling

Conditions

Congenital Pneumonia
Transient Tachypnea of the Newborn

Treatments

Diagnostic Test: complete blood count, CRP, blood smear test, blood culture, chest X- ray

Study type

Observational

Funder types

Other

Identifiers

NCT06803355
BU-PEDS-CA-01

Details and patient eligibility

About

Accurate and timely differentiation between transient tachypnea of the newborn (TTN) and congenital pneumonia is essential in neonatal care, as it facilitates prompt initiation of appropriate treatment, reduces the risk of complications, and minimizes inappropriate antibiotic use. This study aims to assess the clinical utility of inflammatory markers, including the Systemic Immune-Inflammation Index (SII) and the Systemic Immune-Response Index (SIRI), in distinguishing TTN from congenital pneumonia in neonates. In scenarios where conventional diagnostic methods prove insufficient, these indices may offer clinicians a reliable and objective diagnostic approach, thereby optimizing antibiotic stewardship and reducing the duration of hospitalization.

Full description

Patients admitted to the Neonatal Intensive Care Unit of Dr. Behçet Uz Children's Hospital for respiratory distress will be analyzed.

The following data will be recorded in the "case report form" for each patient: age, gender,Score for Neonatal Acute Physiology- Perinatal Extension-II (SNAPPE-II), birth weight (SGA/LGA), mode of delivery (elective/emergency C-section and vaginal delivery), gravidity, parity, maternal age, maternal comorbidities (GDM, preeclampsia/eclampsia, hypothyroidism, chorioamnionitis, urinary tract infection, asthma, obesity, epilepsy), presence of premature rupture of membranes or fever, sibling history, low APGAR score (<7), leukocyte count, neutrophil count, lymphocyte count, platelet count, monocyte count, aspartate transferase (AST), C-reactive protein (CRP), blood smear test, blood culture, tracheal aspirate culture, antibiotics used and their duration, chest X-ray findings, length of hospital stay, onset and duration of oxygen therapy and method of administration, need for mechanical ventilation, and morbidity and mortality status.

Enrollment

35 estimated patients

Sex

All

Ages

1 to 24 hours old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Neonates born at ≥37 weeks of gestation, Admitted within the first 24 hours after birth with respiratory distress and a preliminary diagnosis of TTN

Exclusion criteria

  • Congenital anomalies Genetic syndromes Diagnosis of sepsis Patients without informed consent

Trial design

35 participants in 2 patient groups

congenital pneumonia
Description:
patients diagnosed with congenital pneumonia
Treatment:
Diagnostic Test: complete blood count, CRP, blood smear test, blood culture, chest X- ray
transient tachypnea of the newborn
Description:
patients diagnosed with transient tachypnea of the newborn
Treatment:
Diagnostic Test: complete blood count, CRP, blood smear test, blood culture, chest X- ray

Trial contacts and locations

1

Loading...

Central trial contact

Şebnem Çalkavur, MD; Ceren Akdağ, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems